A Study to Evaluate the Efficacy and Safety of LZM012

A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis

NCT05975268 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2 Study of Jaktinib in Participants With Moderate to Severe Psoriasis

NCT04612699 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis

NCT07008547 ·Status: COMPLETED ·Phase: PHASE3

A Prospective Multicenter Study for the Assessment of Treatment Patterns, Effectiveness and Safety of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis in a Real-world Setting in China

NCT04894890 ·Status: COMPLETED

Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis

NCT04173637 ·Status: COMPLETED ·Phase: PHASE2

A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

NCT06672393 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

NCT01537432 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03536884 ·Status: COMPLETED ·Phase: PHASE3

Real World Study on the Efficacy and Safety of Apremilast in Chinese Patients With Moderate to Severe Plaque Psoriasis, a Multi Center, Prospective, Observational Trial（REACT）

NCT05863273 ·Status: COMPLETED

A Study of IBI112 in Chinese Patients With Psoriasis Who Were Previously Treated With Biologics

NCT05970978 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis

NCT05120297 ·Status: COMPLETED ·Phase: PHASE3

Characteristics of Patients Treated With Secukinumab for Moderate to Severe Plaque Psoriasis

NCT05650060 ·Status: COMPLETED

An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound

NCT04488185 ·Status: WITHDRAWN ·Phase: PHASE4

Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis

NCT01412944 ·Status: COMPLETED ·Phase: PHASE3

Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis

NCT02826603 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

NCT06077331 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis

NCT05003531 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

NCT05531682 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis

NCT02690701 ·Status: COMPLETED ·Phase: PHASE4

Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT05335356 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis

NCT05600036 ·Status: COMPLETED ·Phase: PHASE2

Ixekizumab Versus Secukizumab in Over 70-year-old Patients with Psoriasis

NCT06811558 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis

NCT01177800 ·Status: COMPLETED ·Phase: PHASE3

Plaque Psoriasis Efficacy and Safety With Secukinumab

NCT02409667 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in Adults

NCT04121143 ·Status: SUSPENDED ·Phase: PHASE2